Product
Infex 400 MR
1 clinical trial
3 indications
Indication
SinusitisIndication
AcuteIndication
RhinosinusitisClinical trial
Comparison of the Efficacy and Safety of Immediate (b.i.d) and Modified (q.d.) Release Cefpodoxime Formulations in the Treatment of Acute Sinusitis: a Double-blind, Randomized, Phase III, Non-inferiority Study.Status: Recruiting, Estimated PCD: 2023-10-01